Company Overview: BioLife Solutions, Inc.

What the Company Does
BioLife Solutions, Inc. is a biotechnology and life sciences company focused on biopreservation media, products, and services used in cell and gene therapy, regenerative medicine, and biopharmaceutical manufacturing. The company develops and commercializes biopreservation media solutions, including HypoThermosol and CryoStor product platforms, which are critical for the storage, preservation, and transport of biological tissues, cells, and organs.

Key Business Activities

• Development of biopreservation media for cells, tissues, and organs.
• Provides related products and services, including cell processing equipment and cryogenic storage containers.
• Engages in acquisitions and divestitures to streamline operations and focus on core competencies. In 2024, it divested its Global Cooling, Custom Biogenics, and SciSafe businesses, generating approximately $74.7 million in cash across the year.

Customer and Market Focus

• Serves the cell and gene therapy industry, regenerative medicine, and biopharmaceutical manufacturing.
• Deepens relationships with existing biopreservation media customers and promotes cross-selling of related products.

Financials (2024)

• Revenue: $82.3 million, reflecting an 8% increase compared to 2023.
• Operating Income: The company reported a net loss of approximately $11.4 million.
• Adjusted EBITDA: $15.6 million (positive), which is about 19% of revenue.

Employees and Shareholders

• As of March 27, 2025, the company had 47.5 million shares of common stock outstanding.
• The company employs a workforce, including executives and staff across various functions like scientific research, quality control, marketing, and corporate management.

Shareholder and Market Data

• Market value of common equity (based on June 28, 2024 stock price of $21.43): approximately $784 million.
• The company is publicly traded on The NASDAQ Stock Market, LLC under the ticker symbol BLFS.

Summary
BioLife Solutions specializes in innovative biopreservation media solutions critical for advancing cell and gene therapies and regenerative medicine. It focuses on streamlining its operations through strategic divestitures, expanding its customer base, and maintaining a competitive market position in the biotechnology industry.